6xqq

Publication Abstract from PubMed

MR1 presents vitamin B-related metabolites to mucosal associated invariant T (MAIT) cells, which are characterized, in part, by the TRAV1-2(+) alphabeta T cell receptor (TCR). In addition, a more diverse TRAV1-2(-) MR1-restricted T cell repertoire exists that can possess altered specificity for MR1 antigens. However, the molecular basis of how such TRAV1-2(-) TCRs interact with MR1-antigen complexes remains unclear. Here, we describe how a TRAV12-2(+) TCR (termed D462-E4) recognizes an MR1-antigen complex. We report the crystal structures of the unliganded D462-E4 TCR and its complex with MR1 presenting the riboflavin-based antigen 5-OP-RU. Here, the TRBV29-1 beta-chain of the D462-E4 TCR binds over the F'-pocket of MR1, whereby the complementarity-determining region (CDR) 3beta loop surrounded and projected into the F'-pocket. Nevertheless, the CDR3beta loop anchored proximal to the MR1 A'-pocket and mediated direct contact with the 5-OP-RU antigen. The D462-E4 TCR footprint on MR1 contrasted that of the TRAV1-2(+) and TRAV36(+) TCRs' docking topologies on MR1. Accordingly, diverse MR1-restricted T cell repertoire reveals differential docking modalities on MR1, thus providing greater scope for differing antigen specificities.

Atypical TRAV1-2(-) T cell receptor recognition of the antigen-presenting molecule MR1.,Awad W, Meermeier EW, Sandoval-Romero ML, Le Nours J, Worley AH, Null MD, Liu L, McCluskey J, Fairlie DP, Lewinsohn DM, Rossjohn J J Biol Chem. 2020 Oct 16;295(42):14445-14457. doi: 10.1074/jbc.RA120.015292. Epub, 2020 Aug 14. PMID:32817339^[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.